Search Results - "Le Maitre, A"

Elevated Plasma Ferritin and Busulfan Pharmacodynamics During High-dose Chemotherapy Regimens in Children with Malignant Solid Tumors by Bouligand, J, Maitre, A Le, Valteau‐Couanet, D, Grill, J, Drouard‐Troalen, L, Paci, A, Hartmann, O, Benhamou, E, Vassal, G

“…Hepatic veno‐occlusive disease (HVOD) is a frequent complication during hematopoietic stem‐cell transplantation (HSCT). A strong relationship has been…”
Get full text

Evaluation of respiratory and cardiac motion correction schemes in dual gated PET/CT cardiac imaging by Lamare, F., Le Maitre, A., Dawood, M., Schäfers, K. P., Fernandez, P., Rimoldi, O. E., Visvikis, D.

“…Purpose: Cardiac imaging suffers from both respiratory and cardiac motion. One of the proposed solutions involves double gated acquisitions. Although such an…”
Get full text

Evaluation of clinical IMRT treatment planning using the GATE Monte Carlo simulation platform for absolute and relative dose calculations by Benhalouche, S., Visvikis, D., Le Maitre, A., Pradier, O., Boussion, N.

“…Purpose: The objective of this study was to evaluate and validate the use of the Geant4 application for emission tomography (GATE) Monte Carlo simulation…”
Get full text

OC-0244: Prediction of cumulative bladder DVH in prostate cancer IGRT with a partial least squares (PLS) model by Rios, R, Le Maitre, A, Cazoulat, G, Acosta, O, Espinosa, J, De Crevoisier, R

Get full text

Pharmacogenetic analysis of BR.21, a placebo-controlled randomized phase III clinical trial of erlotinib in advanced non-small cell lung cancer by Liu, Geoffrey, Cheng, D, Ding, K, Le Maitre, A, Liu, N, Patel, D, Chen, Z, Seymour, L, Shepherd, F A, Tsao, M S

“…BR.21 is a double-blind, placebo-controlled trial of second-/third-line erlotinib in stage IIIB/IV non-small cell lung cancer patients. Predictive and…”
Get more information

PO-0853: Cumulated dose estimation in prostate IGRT: Is it necessary to recalculate the dose for each fraction? by Le Maitre, A, Cazoulat, G, Simon, A, Kharchi, L, Acosta, O, Haigron, P, de Crevoisier, R

Get full text

SU‐E‐I‐88: Realistic Pathological Simulations of the NCAT and Zubal Anthropomorphic Models, Based on Clinical PET/CT Data by Papadimitroulas, P, Loudos, G, Le Maitre, A, Efthimiou, N, Visvikis, D, Nikiforidis, G, Kagadis, GC

“…Purpose: In the present study a patient‐specific dataset of realistic PET simulations was created, taking into account the variability of clinical oncology…”
Get full text

How Accurate is Deformable Image Registration to Calculate Cumulative Dose From Fraction to Fraction in Prostate IGRT? by Cazoulat, G, Simon, A, Duménil, A, Acosta, O, Le Maitre, A, Ospina, J.D, Dréan, G, Viard, R, Haigron, P, de Crevoisier, R

Get full text

1166 poster IMPACT OF FUNCTIONAL CONTRAST ON NON-UNIFORM RADIOTHERAPY DOSE PRESCRIPTIONS by Le Maitre, A, Hatt, M, Le Rest, C. Cheze, Pradier, O, Visvikis, D

Get full text

SU‐E‐J‐113: Impact of 4D PET and Motion Correction in the Delineation of Gross Tumor Volume for Radiotherapy Treatment Planning in Lung Cancer by Le Maitre, A, Wallach, D, Hatt, M, Edel, S, Boussion, N, Pradier, O, Visvikis, D

“…Purpose: To quantitatively assess the impact of motion correction in 4D‐PET images on the accuracy of automatic lung tumour volume delineation for radiotherapy…”
Get full text

53 poster: Impact of the Accuracy of Tumor Functional Volume Delineation on Radiotherapy Treatment Planning by Le Maitre, A, Hatt, M, Cheze Le Rest, C, Albarghach, N, Pradier, O, Visvikis, D

Get full text

Concomitant versus neoadjuvant chemotherapy for patients with locally advanced head and neck cancer. Results of two individual patient data meta-analyses by Le Maitre, A, Bourhis, J, Pignon, J.P

Get full text

Role of Spatial Integration in the Morphology of the Bony Labyrinth in Modern Humans by Le Maître, A.

“…The bony labyrinth corresponds to the osseous wall of the inner ear, the hearing and balance organ located in the petrous pyramids, in the base of the cranium…”
Get full text

Adapting dose prescription to tumour heterogeneities: The impact of the functional contrast by Le Maitre, A, Hatt, M, Le Rest, C C, Pradier, O, Visvikis, D

“…Tumours are heterogeneous structures. The evolution of functional imaging techniques and the use of new tracers for PET images allow characterizing tumour…”
Get full text

Image-guided and adaptive radiotherapy by Louvel, G, Cazoulat, G, Chajon, E, Le Maître, A, Simon, A, Henry, O, Bensadoun, R J, de Crevoisier, R

“…Image-guided radiotherapy (IGRT) aims to take into account anatomical variations occurring during irradiation by visualization of anatomical structures. It may…”
Get full text

Evaluation of respiratory and cardiac motion correction schemes in dual gated PET/CT cardiac imaging: Motion correction strategies in dual gated cardiac by Lamare, F., Le Maitre, A., Dawood, M., Schäfers, K. P., Fernandez, P., Rimoldi, O. E., Visvikis, D.

Get full text

Radiothérapie guidée par l’image et adaptative by Louvel, G., Cazoulat, G., Chajon, E., Le Maître, A., Simon, A., Henry, O., Bensadoun, R.J., de Crevoisier, R.

“…La radiothérapie guidée par l’image (image-guided radiotherapy [IGRT]) vise à prendre en compte les variations anatomiques survenant en cours d’irradiation par…”
Get full text

Evaluation of clinical IMRT treatment planning using the GATE Monte Carlo simulation platform for absolute and relative dose calculations: IMRT Monte Carlo simulation with GATE by Benhalouche, S., Visvikis, D., Le Maitre, A., Pradier, O., Boussion, N.

Get full text

An evaluation of the possible interaction of gastric acid suppressive medication and the EGFR tyrosine kinase inhibitor erlotinib by Hilton, J. F., Seymour, L., Le Maitre, A., Tu, D., Shepherd, F. A., Bradbury, P. A.

“…Abstract only…”
Get full text

P2-14-02: NCIC CTG MA.27: Clinical Tolerability and Overall Survival of Racial and Ethnic Minority Women on Aromatase Inhibitor Therapy by Moy, B, Shepherd, LE, Chapman, J-AW, Le, Maitre A, Gelmon, KA, Elliott, C, Ingle, JN, Goss, PE

“…Abstract Background Aromatase inhibitors (AIs) are standard adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer. We…”
Get full text